Ingevity Raises FY2026 Adj EPS Guidance from $4.70-$5.20 to $5.00-$5.45 vs $5.01 Est; Affirms FY2026 Sales Guidance of $1.050B-$1.150B vs $1.109B Est

Benzinga Newsdesk www.benzinga.com Positive 79.5%

Neg 0% Neu 0% Pos 79.5%

Ingevity (NYSE:NGVT) raises FY2026 Adj EPS guidance from $4.70-$5.20 to $5.00-$5.45 vs $5.01 analyst estimate. Affirms FY2026 sales outlook from $1.050 billion-$1.150 billion to $1.050 billion-$1.150 billion vs $1.109 billion estimate.